<p>Meta-analysis of the toxicities in patients with cancer randomly assigned to celecoxib or placebo/no intervention.</p
<p>Meta-analysis of fatal cardiovascular events in RCTs of LABAs compare with placebo.</p
<p>Meta-analysis of time to progression for S-1-based chemotherapy compared with capecitabine-based ...
<p>Meta-analysis of studies examining association between flavonoids consumption and risk of breast ...
<p>Meta-analysis of the reported systemic adverse events observed in non-health subjects receiving s...
<p>A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer - Table 1 </p
<p>Meta-analysis of the reported local adverse events observed in non-healthy subjects receiving ISC...
<p>Meta-analysis of the reported local adverse events observed in non-healthy subjects receiving QS-...
<p>Meta-analysis of the withdrawal rate of the rotigotine and placebo-treated groups.</p
<p>Meta-analysis of adverse events rate ratio comparisons in controls and disulfiram treated patient...
<p>Forest plot showing no statistical significance of the association between p-mTOR expression and ...
<p>Meta-analysis of the log hazard ratios of progression free survival comparing bevacizumab and sta...
<p>Meta-analysis of overall survival for S-1-based chemotherapy compared with capecitabine-based che...
Reporting and publication bias is a well-known problem in meta-analysis and healthcare research. In ...
<p>Meta-analysis of overall response rate for S-1-based chemotherapy compared with capecitabine-base...
<p>Meta-analysis of randomized controlled trials evaluating doses of pain medication.</p
<p>Meta-analysis of fatal cardiovascular events in RCTs of LABAs compare with placebo.</p
<p>Meta-analysis of time to progression for S-1-based chemotherapy compared with capecitabine-based ...
<p>Meta-analysis of studies examining association between flavonoids consumption and risk of breast ...
<p>Meta-analysis of the reported systemic adverse events observed in non-health subjects receiving s...
<p>A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer - Table 1 </p
<p>Meta-analysis of the reported local adverse events observed in non-healthy subjects receiving ISC...
<p>Meta-analysis of the reported local adverse events observed in non-healthy subjects receiving QS-...
<p>Meta-analysis of the withdrawal rate of the rotigotine and placebo-treated groups.</p
<p>Meta-analysis of adverse events rate ratio comparisons in controls and disulfiram treated patient...
<p>Forest plot showing no statistical significance of the association between p-mTOR expression and ...
<p>Meta-analysis of the log hazard ratios of progression free survival comparing bevacizumab and sta...
<p>Meta-analysis of overall survival for S-1-based chemotherapy compared with capecitabine-based che...
Reporting and publication bias is a well-known problem in meta-analysis and healthcare research. In ...
<p>Meta-analysis of overall response rate for S-1-based chemotherapy compared with capecitabine-base...
<p>Meta-analysis of randomized controlled trials evaluating doses of pain medication.</p
<p>Meta-analysis of fatal cardiovascular events in RCTs of LABAs compare with placebo.</p
<p>Meta-analysis of time to progression for S-1-based chemotherapy compared with capecitabine-based ...
<p>Meta-analysis of studies examining association between flavonoids consumption and risk of breast ...